University of Oklahoma’s smoking cessation app performs well in clinical trial
Peer-Reviewed Publication
Updates every hour. Last Updated: 24-Dec-2025 03:11 ET (24-Dec-2025 08:11 GMT/UTC)
OKLAHOMA CITY – While smoking rates in the United States have substantially declined over the past six decades, smoking remains high among people with low incomes, leading to health disparities. A smartphone app that delivers real-time, tailored messages may hold the key to helping them quit, according to University of Oklahoma clinical trial results published today in JAMA Network Open.
The antibody also has potential to treat a broad array of other conditions, including autoimmune disorders, cancer and diabetes, research indicates.
With help from artificial intelligence, MIT researchers designed novel antibiotics that can combat a drug-resistant form of Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA).